PMID- 36797098 OWN - NLM STAT- MEDLINE DCOM- 20230308 LR - 20230421 IS - 1873-2518 (Electronic) IS - 0264-410X (Print) IS - 0264-410X (Linking) VI - 41 IP - 12 DP - 2023 Mar 17 TI - Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022. PG - 1943-1950 LID - S0264-410X(23)00157-3 [pii] LID - 10.1016/j.vaccine.2023.02.022 [doi] AB - INTRODUCTION: In 2021, HHS Office of Minority Health and CDC developed a composite measure of social vulnerability called the Minority Health Social Vulnerability Index (MHSVI) to assess the needs of communities most vulnerable to COVID-19. The MHSVI extends the CDC Social Vulnerability Index with two new themes on healthcare access and medical vulnerability. This analysis examines COVID-19 vaccination coverage by social vulnerability using the MHSVI. METHODS: County-level COVID-19 vaccine administration data among persons aged >/=18 years reported to CDC from 12/14/20 to 01/31/22 were analyzed. U.S. counties from 50 states and DC were categorized into tertiles of vulnerability (low, moderate, and high) for the composite MHSVI measure and each of the 34 indicators. Vaccination coverage (>/=1 dose, primary series completion, and receipt of a booster dose) was calculated by tertiles for the composite MHSVI measure and each indicator. RESULTS: Counties with lower per capita income, higher proportion of individuals with no high school diploma, living below poverty, >/=65 years of age, with a disability, and in mobile homes had lower vaccination uptake. However, counties with larger proportions of racial/ethnic minorities and individuals speaking English less than "very well" had higher coverage. Counties with fewer primary care physicians and greater medical vulnerabilities had lower >/= 1 dose vaccination coverage. Furthermore, counties of high vulnerability had lower primary series completion and receipt of a booster dose. There were no clear patterns in COVID-19 vaccination coverage by tertiles for the composite measure. CONCLUSION: Results from the new components in the MHSVI identify needs to prioritize persons in counties with greater medical vulnerabilities and limited access to health care, who are at greater risk for adverse COVID-19 outcomes. Findings suggest that using a composite measure to characterize social vulnerability might mask disparities in COVID-19 vaccination uptake that would have otherwise been observed using specific indicators. CI - Published by Elsevier Ltd. FAU - Saelee, Ryan AU - Saelee R AD - Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States. Electronic address: eocevent534@cdc.gov. FAU - Chandra Murthy, Neil AU - Chandra Murthy N AD - Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States; Commisioned Corps of the United State Public Health Service, United States. FAU - Patel Murthy, Bhavini AU - Patel Murthy B AD - Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States. FAU - Zell, Elizabeth AU - Zell E AD - CDC COVID-19 Response Team, United States; Stat-Epi Associates, Inc., Ponte Vedra Beach, FL, United States. FAU - Shaw, Lauren AU - Shaw L AD - Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States. FAU - Gibbs-Scharf, Lynn AU - Gibbs-Scharf L AD - Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States. FAU - Harris, LaTreace AU - Harris L AD - Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States. FAU - Shaw, Kate M AU - Shaw KM AD - Office of Science, National Center for Injury Prevention and Control, CDC, United States. LA - eng PT - Journal Article DEP - 20230213 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (COVID-19 Vaccines) SB - IM MH - Humans MH - United States/epidemiology MH - Adolescent MH - Adult MH - *COVID-19 Vaccines MH - Vaccination Coverage MH - Minority Health MH - Social Vulnerability MH - *COVID-19/prevention & control MH - Vaccination PMC - PMC9922574 OTO - NOTNLM OT - COVID-19 vaccines OT - Minority health OT - Social vulnerability OT - Vaccination coverage OT - Vaccine uptake COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/02/17 06:00 MHDA- 2023/03/09 06:00 PMCR- 2023/02/13 CRDT- 2023/02/16 22:01 PHST- 2022/04/20 00:00 [received] PHST- 2023/01/25 00:00 [revised] PHST- 2023/02/08 00:00 [accepted] PHST- 2023/02/17 06:00 [pubmed] PHST- 2023/03/09 06:00 [medline] PHST- 2023/02/16 22:01 [entrez] PHST- 2023/02/13 00:00 [pmc-release] AID - S0264-410X(23)00157-3 [pii] AID - 10.1016/j.vaccine.2023.02.022 [doi] PST - ppublish SO - Vaccine. 2023 Mar 17;41(12):1943-1950. doi: 10.1016/j.vaccine.2023.02.022. Epub 2023 Feb 13.